Cargando…
Methylation Status of the Nanog Promoter Determines the Switch between Cancer Cells and Cancer Stem Cells
Cancer stem cells (CSCs) are the main cause of tumor development, metastasis, and relapse. CSCs are thus considered promising targets for cancer therapy. However, it is hard to eradicate CSCs due to their inherent plasticity and heterogeneity, and the underlying mechanism of the switch between non‐C...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055559/ https://www.ncbi.nlm.nih.gov/pubmed/32154082 http://dx.doi.org/10.1002/advs.201903035 |